C2I Accelerator
Overview
C2I Accelerator is a life science incubator and accelerator based in Woburn, Massachusetts, founded in 2013. It focuses on supporting early-stage life science companies by providing fully equipped laboratory and office space, access to professional services, advisors, consultants, and investors. The facility, which is chemistry-focused, spans approximately 20,000-22,000 sq ft and includes chemistry, biology, and tissue culture labs. The accelerator's mission is to foster the next generation of life science entrepreneurs. C2I has incubated over 65 companies since its inception. The accelerator was founded based on the chemistry expertise of its parent/affiliated company, CreaGen BioSciences.
Portfolio Companies
2
Website
creagenincubator.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| MarvelBiome Inc. | Nov 2020 | Seed | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is C2I Accelerator based?
C2I Accelerator is headquartered in Woburn, Massachusetts, United States.
When was C2I Accelerator founded?
Founding year information for C2I Accelerator is not publicly available.
How many portfolio companies does C2I Accelerator have?
C2I Accelerator has 2 portfolio companies in Caplight's dataset.
What are some companies in C2I Accelerator's portfolio?
Portfolio companies visible on Caplight include MarvelBiome Inc..
What was C2I Accelerator's most recent investment shown here?
C2I Accelerator's most recent investment in this portfolio sample was in MarvelBiome Inc. in 2020.
What sectors does C2I Accelerator focus on?
C2I Accelerator focuses on Healthcare & Life Sciences, Frontier & Industrial Tech, Energy & Sustainability.
What company stages does C2I Accelerator focus on?
C2I Accelerator typically invests at the Early stage.